NetworkNewsBreaks

MondayMar 31, 2025 9:00 am

NetworkNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Closes CA$237,106 Private Placement to Support U.S. Expansion

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a Swiss-hosted cybersecurity and privacy communications platform, announced the closing of the final tranche of its non-brokered private placement, raising gross proceeds of CA$237,106. The offering included 6,973,705 units priced at CA$0.034, each consisting of one common share and one full warrant exercisable at CA$0.055 for 24 months. Company insiders, including the CEO, CFO and a board member, collectively purchased 2,050,000 units. Proceeds will be used to expand U.S. marketing efforts and support general corporate purposes. To view the full press release, visit https://nnw.fm/KOw0k About Sekur Private Data Ltd. Sekur Private…

Continue Reading

FridayMar 28, 2025 3:39 pm

NetworkNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Develop 7.2 MW Hoadley Hill Rd Solar Project

Disseminated on behalf of SolarBank Corporation  SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) has announced plans to develop a 7.2 MW DC ground-mount solar power project known as the Hoadley Hill Rd project (the “Project”) on a site located in upstate New York. According to the announcement, the Project is another key addition to SolarBank's expanding development pipeline—which exceeds one gigawatt—as well as the company's commitment to advancing community solar. Assuming receipt of the requested interconnection approval, SolarBank will continue efforts to complete the permitting process and secure necessary financing for construction of the Project. The Project is expected…

Continue Reading

FridayMar 28, 2025 3:25 pm

NetworkNewsBreaks – Titan Partners Group LLC Acts as Sole Bookrunner for $10.5M Underwritten Offering 

Titan Partners Group, a division of American Capital Partners LLC, is acting as sole bookrunner for an underwritten offering of Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company. Genelux recently announced pricing of the offering, which consists of 3,000,000 shares of its common stock, each at an offering price of $3.50. Genelux expects approximately $10.5 million in gross proceeds from the offering, of which it intends to use the net for working capital and general corporate purposes, including the continued clinical development of Olvi-Vec.  To view the full press release, visit https://nnw.fm/MOjh7  About Titan Partners Group LLC  Titan Partners…

Continue Reading

FridayMar 28, 2025 2:05 pm

NetworkNewsBreaks – Upstream Enhances KYC Process to Streamline User Experience

Upstream published a blog today that discussed ongoing efforts to enhance the trading experience via its innovative platform. The latest upgrade to Upstream’s KYC (Know Your Customer) identity verification process makes it more intuitive and seamless for users. The redesigned interface ensures a smoother experience while maintaining quick and secure verification, which is essential for preventing fraud and illicit activity. Users are prompted to complete KYC once their account balance reaches $500 or when withdrawing funds, though they can initiate verification at any time through the profile settings. Verification can take as little as 15 minutes or up to two…

Continue Reading

FridayMar 28, 2025 11:44 am

NetworkNewsBreaks – Zacks Maintains $35.00 Price Per Share Valuation for Soligenix Inc. (NASDAQ: SNGX) Amid Promising Vaccine and CTCL Therapy Progress 

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a recent Zacks Small-Cap Research report that presented a favorable analysis, emphasizing the company's advancements in vaccine and photodynamic therapy technologies.  The study highlights promising preclinical data for CiVax(TM), a thermostabilized COVID-19 booster, which demonstrated broad immune protection in non-human primates. Zacks also notes the continued progress of HyBryte(TM), Soligenix’s lead candidate for cutaneous T-cell lymphoma (“CTCL”), now in a second confirmatory Phase 3 trial, following successful results in its first Phase 3 study. Based on its discounted cash flow model that takes into account potential future…

Continue Reading

FridayMar 28, 2025 9:45 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Announces $3.9 Million Registered Direct Offering and Private Placement 

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company advancing targeted immunotherapies, has entered into a securities purchase agreement with a single institutional investor for a registered direct offering of 3,325,000 shares of common stock at $0.65 per share, or pre-funded warrants in lieu of stock. Concurrently, the company will issue series G warrants to purchase up to 6,053,000 shares of common stock in a private placement. The total gross proceeds from both transactions are expected to be approximately $3.9 million before fees and expenses. Ladenburg Thalmann & Co. Inc. is acting as the exclusive placement agent. Calidi plans to…

Continue Reading

ThursdayMar 27, 2025 3:58 pm

NetworkNewsBreaks – Powered by Physics: Newton Golf Company’s (NASDAQ: NWTG) Rebrand Spotlights Game-Changing Technology

Newton Golf (NASDAQ: NWTG) has completed a strategic rebranding to emphasize its commitment to innovation and align more closely with its mission of integrating advanced physics principles into golf-equipment design. The restructuring was not merely a change in name but a reflection of Newton Golf’s dedication to creating equipment that leverages the laws of physics to benefit golfers of all skill levels. Central to the company’s product lineup are the Newton Gravity Putters and Newton Motion Shafts. Renowned for their ultra-low balance point (“ULBP”) technology, the gravity putters promote a smoother, more controlled putting stroke. The innovation has garnered attention on…

Continue Reading

ThursdayMar 27, 2025 2:59 pm

NetworkNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positioning at the Forefront of Next-Gen Energy Storage

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is a frontrunner in lithium-sulfur battery innovation through its subsidiary, Lion Battery Technologies. By leveraging the unique properties of platinum and palladium, PLG is improving the efficiency and longevity of these batteries, which offer higher energy density, lower production costs, and environmental benefits compared to traditional lithium-ion batteries. With significant progress made in research, including testing at the Battery Innovation Center and securing key patents, PLG is positioning itself as a leader in next-generation energy storage. Aligned with global demand, PLG’s efforts position the company at the cutting-edge of this exciting technological frontier,…

Continue Reading

ThursdayMar 27, 2025 12:35 pm

NetworkNewsBreaks – TransCode Therapeutics Inc. (NASDAQ: RNAZ) Secures $10M in Registered Direct Offering

TransCode (NASDAQ: RNAZ), the oncology company committed to utilizing RNA therapeutics to more effectively treat cancer, has announced the closing of its sale of 10,250,000 shares of its common stock and warrants to purchase up to 10,250,000 shares of common stock priced at-the-market under Nasdaq rules, at a purchase price of $0.98 per share and accompanying warrant. The company secured approximately $10 million in gross proceeds from the offering. TransCode intends to use the proceeds primarily for product development activities, including one or more clinical trials with its lead therapeutic candidate, TTX-MC138, including related IND-enabling studies, as well as for…

Continue Reading

ThursdayMar 27, 2025 12:26 pm

NetworkNewsBreaks – CISO Global Inc.’s (NASDAQ: CISO) Achieves Profitability Milestone as Software-Led Strategy Takes Hold

CISO Global (NASDAQ: CISO) announced it achieved unaudited positive Adjusted EBITDA in Q4 2024, marking a pivotal profitability milestone as it transitions from a cyber services company to a software-led, AI-powered cybersecurity enterprise. The company credits this progress to integrating 13 acquisitions, cutting costs through proprietary AI-driven security solutions and increasing high-margin software revenue. CISO expects at least $34 million in profitable services revenue and $5 million in software bookings for 2025, with software margins projected around 75%, supported by a robust sales pipeline and insurance partnerships.  To view the full article, visit https://www.nnw.fm/xtTeC  About CISO Global Inc.  CISO Global…

Continue Reading